A Longitudinal Study of Trajectories and Factors Influencing Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease

References

• Halpin DM, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD Science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36. doi:10.1164/rccm.202009-3533SO
   PubMed Web of Science ®Google Scholar
• Vos T, Allen C, Arora M, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. doi:10.1016/S0140-6736(18)32335-3
   PubMed Web of Science ®Google Scholar
• World Health Organization. Projections of mortality and causes of death, 2016 and 2060. Available from; https://www.who.inthealthinfo/global_burden_disease/projections/en/.html,2019-10-14/2022-05-29. Accessed November 9, 2022.
   Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Ejiofor SI, Stolk J, Fernandez P, et al. Patterns and characterization of COPD exacerbations using real-time data collection. Int J Chron Obstruct Pulmon Dis. 2017;12:427–434. doi:10.2147/COPD.S126158
   PubMed Web of Science ®Google Scholar
• Kluetz PG, O’connor DJ, Soltys K. Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada. Lancet. 2018;19(5):e267–e274. doi:10.1016/S1470-2045(18)30097-4
   Web of Science ®Google Scholar
• Global Initiative for Chronic Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2020 report; 2020. Available from: https://goldCOPD.org/gold-reports/.html,2019-11-05/2022-01-08. Accessed November 9, 2022.
   Google Scholar
• Health and quality of life outcomes. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance; 2006:79.
   Google Scholar
• Vanderhout S, Fergusson DA, Cook JA, et al. Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: a cross-sectional analysis. PLoS Med. 2022;19(2):e1003896. doi:10.1371/journal.pmed.1003896
   PubMed Web of Science ®Google Scholar
• Corbin JM. The Corbin and Strauss Chronic Illness Trajectory model: an update. Sch Inq Nurs Pract. 1998;12(1):33–41.
   PubMedGoogle Scholar
• Celli BR, Anderson JA, Cowans NJ, et al. Pharmacotherapy and lung function decline in patients with chronic obstructive pulmonary disease. A systematic review. Am J Respir Crit Care Med. 2021;203(6):689–698. doi:10.1164/rccm.202005-1854OC
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Xie Y, et al. Development and validation of the modified patient-reported outcome scale for chronic obstructive pulmonary disease (mCOPD-PRO). Int J Chron Obstruct Pulmon Dis. 2020;15:661–669. doi:10.2147/COPD.S240842
   PubMed Web of Science ®Google Scholar
• Health Quality Ontario. Effect of early follow-up after hospital discharge on outcomes in patients with heart failure or chronic obstructive pulmonary disease: a systematic review. Ont Health Technol Assess Ser. 2017;17(8):1.
   Google Scholar
• Suissa S, Dell’aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963. doi:10.1136/thoraxjnl-2011-201518
   PubMed Web of Science ®Google Scholar
• Goz V, Lakomkin N. Reliability of SRS-22 and ODI by phone: a step toward making PROs more accessible. Spine J. 2016;16(9):1047–1048. doi:10.1016/j.spinee.2016.05.011
   PubMed Web of Science ®Google Scholar
• Qian T, Masino AJ. Latent patient cluster discovery for robust future forecasting and new-patient generalization. PLoS One. 2016;11(9):e0162812. doi:10.1371/journal.pone.0162812
   PubMed Web of Science ®Google Scholar
• Ding M, Chavarro JE, Fitzmaurice GM. Development of a mixture model allowing for smoothing functions of longitudinal trajectories. Stat Methods Med Res. 2021;30(2):549–562. doi:10.1177/0962280220966019
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, müllerová H, Smeeth L, et al. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(4):464–471. doi:10.1164/rccm.201710-2029OC
   PubMed Web of Science ®Google Scholar
• Wang R-H, K-C Lin, H-C Hsu, et al. Determinants for quality of life trajectory patterns in patients with type 2 diabetes. Qual Life Res. 2019;28(2):481–490. doi:10.1007/s11136-018-2013-2
   PubMed Web of Science ®Google Scholar
• Aza A, Verdugo MÁ, Orgaz MB, et al. Predictive factors of self-reported quality of life in acquired brain injury: one-year follow-up. Int J Environ Res Public Health. 2021;18:3. doi:10.3390/ijerph18030927
   Web of Science ®Google Scholar
• Gardener AC, Ewing G, Kuhn I, et al. Support needs of patients with COPD: a systematic literature search and narrative review. Int J Chron Obstruct Pulmon Dis. 2018;13:1021–1035. doi:10.2147/COPD.S155622
   PubMed Web of Science ®Google Scholar
• Jackson DS, Banerjee S, Sirey JA, et al. Two interventions for patients with major depression and severe chronic obstructive pulmonary disease: impact on quality of life. Am J Geriatr Psychiatry. 2019;27(5):502–511. doi:10.1016/j.jagp.2018.12.004
   PubMed Web of Science ®Google Scholar
• Perez TA, Castillo EG, Ancochea J, et al. Sex differences between women and men with COPD: a new analysis of the 3CIA study. Respir Med. 2020;171:106105. doi:10.1016/j.rmed.2020.106105
   PubMed Web of Science ®Google Scholar
• Christensen VL, Rustøen T, Cooper BA, et al. Distinct symptom experiences in subgroups of patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1801–1809. doi:10.2147/COPD.S105299
   PubMed Web of Science ®Google Scholar
• Han MK. Erratum: chronic obstructive pulmonary disease in women: a biologically focused review with a systematic search strategy [Corrigendum]. Int J Chron Obstruct Pulmon Dis. 2021;16:3017–3018. doi:10.2147/COPD.S346814
   PubMed Web of Science ®Google Scholar
• Gut-gobert C, Cavaillès A, Dixmier A, et al. Women and COPD: do we need more evidence? Eur Respir Rev. 2019;28:151. doi:10.1183/16000617.0055-2018
   Web of Science ®Google Scholar
• Ragland MF, Strand M, Baraghoshi D, et al. 10-year follow-up of lung function, respiratory symptoms, and functional capacity in the COPD gene study. Ann Am Thorac Soc. 2022;19(3):381–388. doi:10.1513/AnnalsATS.202007-873OC
   PubMed Web of Science ®Google Scholar
• Korpershoek Y, Bos-touwen ID, Man-van DE, et al. Determinants of activation for self-management in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1757–1766. doi:10.2147/COPD.S109016
   PubMed Web of Science ®Google Scholar
• Spelta F, Fratta pasini AM, Cazzoletti L, et al. Body weight and mortality in COPD: focus on the obesity paradox. EWD. 2018;23(1):15–22. doi:10.1007/s40519-017-0456-z
   Web of Science ®Google Scholar
• Hogea S-P, Tudorache E, Fildan AP, et al. Risk factors of chronic obstructive pulmonary disease exacerbations. Clin Respir J. 2020;14(3):183–197. doi:10.1111/crj.13129
   PubMed Web of Science ®Google Scholar
• Lange P, Ahmed E, Lahmar ZM, et al. Natural history and mechanisms of COPD. Respirology. 2021;26(4):298–321. doi:10.1111/resp.14007
   PubMed Web of Science ®Google Scholar
• Li X, Wu Z, Xue M, et al. Smoking status affects clinical characteristics and disease course of acute exacerbation of chronic obstructive pulmonary disease: a prospectively observational study. Chron Respir Dis. 2020;17:1479973120916184. doi:10.1177/1479973120916184
   Web of Science ®Google Scholar
• Ghosh AJ, Hobbs BD. Comorbidity-based clusters contain chaos in COPD. Chest. 2020;158(1):11–12. doi:10.1016/j.chest.2020.03.016
   PubMed Web of Science ®Google Scholar
• Divo M, Celli BR. Multimorbidity in patients with chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):405–419. doi:10.1016/j.ccm.2020.06.002
   PubMed Web of Science ®Google Scholar
• Peng X, Huang M, Zhao W, et al. 彭显如,黄敏於,赵文驱,等.首诊慢阻肺错失早期诊断时间与疾病严重程度相关[J].南方医科大学学报[Delayed diagnosis is associated with greater disease severity of chronic obstructive pulmonary disease]. J South Med Univ. 2018;38(12):1448–1452. [ Chinese]. doi:10.12122/j.issn.1673-4254.2018.12.08
   Google Scholar
• Kakavas S, Kotsiou OS, Perlikos F, et al. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ Prim Care Respir Med. 2021;31(1):23. doi:10.1038/s41533-021-00236-w
   PubMed Web of Science ®Google Scholar
• Polsky MB, Moraveji N. Early identification and treatment of COPD exacerbation using remote respiratory monitoring. Respir Med Case Rep. 2021;34:101475. doi:10.1016/j.rmcr.2021.101475
   PubMed Web of Science ®Google Scholar